IPM.ai: Uncovering Ideal Patient and HCP Populations

IPM.ai transforms real-world data into real-world insights across the product lifecycle, uncovering your ideal patient and the healthcare ecosystem in which they live. We empower life sciences companies to accelerate development and commercialization of life-saving therapies for specialty and rare diseases, delivering optimal patient outcomes quicker and with less risk.

Commercial
Effectiveness

We optimize product launch
and peak sales attainment by
uncovering the highest-value
patient targets and providing
actionable intelligence to engage
with treating HCPs for disease
interception and intervention
education.

Clinical Study
Recruitment

We accelerate clinical trial
recruitment by uncovering medically
eligible patients with the highest
likelihood of enrollment/retention.
We optimize site and investigator
selection by linking ideal study
populations with treating HCPs,
inferred specialists and KOLs/KOIs.

Market
Sizing

We confirm research and
development efforts are warranted
and improve investment and exit
options by validating the patient
population with a high probability
of disease manifestation and
forecasting likely demand by linking
treating HCPs, inferred specialists
and KOLs/KOIs.

Contact Daniel Fisher at dfisher@realchemistry.com to learn more.